How Monoclonal Antibodies Can Treat COVID-19 and What the Data Says About Vaccines

Brian Orelli, PhD, The Motley Fool
·3-min read

Monoclonal antibodies from Regeneron (NASDAQ: REGN) and Eli Lilly (NYSE: LLY) designed to bind to the novel coronavirus have delivered solid clinical trial data suggesting they can help patients with COVID-19. In this Fool Live video, Healthcare and Cannabis Bureau Chief Corinne Cardina and longtime Motley Fool contributor Brian Orelli discuss the difference between monoclonal and polyclonal antibodies. Corinne Cardina: What is the difference between a polyclonal versus a monoclonal approach?